We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Usana Health Sciences
USNA
$419M
| $7.3M | 0.03% |
264,973
-85,632
| -24% | -$2.63M |
|
352
Regency Centers
REG
$14.9B
| $7.29M | 0.03% |
99,966
-5,415
| -5% | -$386K |
|
353
PC Connection
CNXN
$2.09B
| $7.25M | 0.03% |
116,878
+3,666
| +3% | +$234K |
|
354
PubMatic
PUBM
$608M
| $7.05M | 0.03% |
851,683
-26,101
| -3% | -$266K |
|
355
Lantheus
LNTH
$6.51B
| $7.02M | 0.03% |
+136,924
| New | +$8.56M |
|
356
CAVA Group
CAVA
$7.61B
| $7M | 0.03% |
115,918
+109,142
| +1,611% | +$8.27M |
|
357
Wells Fargo
WFC
$254B
| $6.93M | 0.03% |
82,630
-110,064
| -57% | -$8.93M |
|
358
Cooper-Standard Automotive
CPS
$517M
| $6.92M | 0.03% |
187,297
-25,324
| -12% | -$772K |
|
359
HP
HPQ
$26B
| $6.77M | 0.03% |
+248,487
| New | +$6.62M |
|
360
W.W. Grainger
GWW
$64.2B
| $6.77M | 0.03% |
7,099
+3,093
| +77% | +$3.11M |
|
361
Dole
DOLE
$1.38B
| $6.74M | 0.03% |
501,409
+22,902
| +5% | +$321K |
|
362
Verisk Analytics
VRSK
$27.9B
| $6.72M | 0.03% |
26,736
+5,208
| +24% | +$1.43M |
|
363
Insteel Industries
IIIN
$592M
| $6.72M | 0.03% |
175,284
+12,177
| +7% | +$460K |
|
364
Paysafe
PSFE
$443M
| $6.67M | 0.03% |
516,289
+9,947
| +2% | +$133K |
|
|
NXDR
365
Nextdoor Holdings
NXDR
$885M
| $6.66M | 0.03% |
3,187,166
+532,267
| +20% | +$1.03M |
|
366
FB Financial Corp
FBK
$2.98B
| $6.66M | 0.03% |
119,427
-72,210
| -38% | -$3.67M |
|
367
G-III Apparel Group
GIII
$1.54B
| $6.62M | 0.03% |
248,672
-121,237
| -33% | -$3.07M |
|
368
Harmony Biosciences
HRMY
$2.08B
| $6.61M | 0.03% |
239,772
-21,854
| -8% | -$753K |
|
369
Varex Imaging
VREX
$462M
| $6.57M | 0.03% |
529,793
+26,488
| +5% | +$263K |
|
370
Clearwater Paper
CLW
$348M
| $6.46M | 0.03% |
311,192
-4,464
| -1% | -$108K |
|
|
BAND
371
Bandwidth Inc
BAND
$1.18B
| $6.44M | 0.03% |
386,339
-87,800
| -19% | -$1.35M |
|
372
MediaAlpha
MAX
$746M
| $6.38M | 0.03% |
560,765
+91,204
| +19% | +$1.01M |
|
373
Palantir
PLTR
$295B
| $6.35M | 0.03% |
34,802
+20,310
| +140% | +$3.29M |
|
374
Robinhood
HOOD
$80.7B
| $6.34M | 0.03% |
44,289
-21,198
| -32% | -$2.31M |
|
375
Leonardo DRS
DRS
$12.4B
| $6.33M | 0.03% |
139,407
-334,536
| -71% | -$14.6M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.